Skip to Content

Porcine Pili Shield (Canada)

This page contains information on Porcine Pili Shield for veterinary use.
The information provided typically includes the following:
  • Porcine Pili Shield Indications
  • Warnings and cautions for Porcine Pili Shield
  • Direction and dosage information for Porcine Pili Shield

Porcine Pili Shield

This treatment applies to the following species:
Company: Elanco

Escherichia Coli Bacterin

For Use in Animals Only

Porcine Pili Shield Indications

For use in healthy pregnant swine as an aid in the control of disease in piglets caused by K88, K99, 987P, and F41 piliated Escherichia coli.

ADJUVANT: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 2 mL intramuscularly 5 and 2 weeks prior to farrowing. Revaccinate prior to each subsequent farrowing.

Precautions

Store out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. Use entire contents when first opened. In case of human exposure, contact a physician. Do not vaccinate within 21 days prior to slaughter. It is essential that newborn pigs receive colostrum from the vaccinated dam. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Manufactured by Elanco US Inc., Fort Dodge, IA, USA.

USDA Vet. Biologics Est. Lic. No. 196.

For Elanco Canada Limited, Guelph, Ontario, Canada N1G 4T2; 1-800-265-5475.

Porcine Pili Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

50 Doses

100 mL

YL101223X

CPN: 1231081.6

ELANCO CANADA LIMITED
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
Telephone:   519-821-0277
Customer Service:   800-387-6325
Fax:   519-821-7831
Every effort has been made to ensure the accuracy of the Porcine Pili Shield information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2019-09-30

Hide